1.
Feng X, Zhu S, Yan Z, Wang C, Tong W, Xu W. PDGFRB as a potential therapeutic target of ankylosing spondylitis: validation following bioinformatics analysis. Cell Mol Biol (Noisy-le-grand) [Internet]. 2020 Sep. 30 [cited 2024 Nov. 22];66(6):127-34. Available from: http://cellmolbiol.org/index.php/CMB/article/view/3653